Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Immunology analyses NEC
ADR ID BADD_A02256
ADR Hierarchy
13      Investigations
13.06      Immunology and allergy investigations
13.06.03      Immunology analyses NEC
Description Not Available
MedDRA Code 10021504
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00041Adalimumab--
BADD_D00048Aflibercept--
BADD_D00053Albiglutide--
BADD_D00062Aldesleukin--
BADD_D00064Alemtuzumab--
BADD_D00141Anakinra--
BADD_D00223Belatacept--
BADD_D00282Blinatumomab--
BADD_D00290Botulinum toxin type a--
BADD_D00335Calcitonin--
BADD_D00378Cefaclor--
BADD_D00561Cytarabine hydrochloride--
BADD_D00685Dinutuximab--
BADD_D00723Doxorubicin--
BADD_D00733Dulaglutide--
BADD_D00738Ecallantide--
BADD_D00742Eculizumab--
BADD_D00758Elosulfase alfa--
BADD_D00808Erythropoietin--
BADD_D00838Etanercept--
BADD_D00859Evolocumab--
BADD_D01035Golimumab--
BADD_D01067Hex-hgrf--
BADD_D01165Insulin lispro--
BADD_D01249Laronidase--
BADD_D01298Liraglutide--
BADD_D01369Mefloquine--
BADD_D01448Metreleptin--
BADD_D01474Mipomersen sodium--
BADD_D01581Nivolumab--
The 1th Page    1 2    Next   Last    Total 2 Pages